Price of J & J ’s TB drug to drop by more than half

Life-saving drug bedaquiline by US pharma company Johnson& Johnson (J&J) is now being offered at $400 per patient —over 50% cheaper than the earlier price of $900.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news